Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Neuroblastoma 2Renal Insufficiency, Chronic 1

Interventions

Cyclophosphamide 14Temozolomide 10Magnetic Resonance Spectroscopy 10Biopsy 9dinutuximab 8X-Rays 8Specimen Handling 8Irinotecan 8Phantoms, Imaging 7fludarabine 6Topotecan 6Nuclear Medicine Department, Hospital 6Vincristine 53-Iodobenzylguanidine 5fludarabine phosphate 4Melphalan 4Granulocyte-Macrophage Colony-Stimulating Factor 4Etoposide 4tipifarnib 3sargramostim 3Radiotherapy 3Isotretinoin 3Filgrastim 3Doxorubicin 3Carboplatin 3ulixertinib 2tazemetostat 2selpercatinib 2saponin QA-21V1 2pembrolizumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Neuroblastoma × saponin QA-21V1 × 90 days × Clear all
NCT06057948 2026-06-05

A Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
94 enrolled
CNS

Neuroblastoma

NCT04936529 2026-05-07

A Study of a Vaccine in Combination With β-glucan and GM-CSF in People With Neuroblastoma

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
286 enrolled
CNS

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡